← All trials
NCT05830955
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2023
- Primary completion
- May 15, 2024
- Completion date
- Nov 15, 2024
- First posted
- Apr 26, 2023
- Last posted
- Oct 19, 2023
- Enrollment
- 54
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mustafa Kemal UniversityLead sponsor
- Mustafa Kemal UniversityReponsible party - principal investigator
- Yuzuncu Yıl UniversityCollaborator
- Istanbul UniversityCollaborator
- Van Training and Research HospitalCollaborator
- Mustafa Kemal UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.